These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11366134)

  • 21. Protease inhibitors.
    Schouten JT
    STEP Perspect; 1995; 7(3):12-3. PubMed ID: 11362981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adefovir dipivoxil trials: CD4 100-500, protease inhibitor naive.
    AIDS Treat News; 1997 Sep; (No 278):6. PubMed ID: 11364624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What they say about protease inhibitors.
    Posit Aware; 1999; 10(1):38-43. PubMed ID: 11366522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children.
    Resino S; Larrú B; Maria Bellón J; Resino R; de José MI; Navarro M; Léon JA; Ramos JT; Mellado MJ; Muñoz-Fernández MA
    BMC Infect Dis; 2006 Jul; 6():107. PubMed ID: 16834769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The new drugs and how to use them.
    Gallant JE
    Hopkins HIV Rep; 1999 Jan; 11(1):2, 7. PubMed ID: 11366160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The steady-state pharmacokinetics of nelfinavir in combination with tenofovir in HIV-infected patients.
    Kruse G; Esser S; Stocker H; Breske A; Koerber A; Kopperman M; Wiehler H; Ross B; Möcklinghoff C; Hill A; Becker M; Kurowski M
    Antivir Ther; 2005; 10(2):349-55. PubMed ID: 15865230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The latest antiviral news.
    Vazquez E
    Posit Aware; 1999; 10(2):44. PubMed ID: 11366851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adefovir dipivoxil (Preveon) expanded access begins.
    AIDS Treat News; 1997 Dec; (No 285):5-6. PubMed ID: 11364918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adefovir dipivoxil (Preveon) expanded access restrictions being eased.
    James JS
    AIDS Treat News; 1998 Feb; (No 288):4-5. PubMed ID: 11365045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What's new, what's next?
    Elwell A
    Posit Dir News; 1999; 11(1):1, 3-13. PubMed ID: 11366098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New anti-HIV drugs in development.
    Proj Inf Perspect; 1999 Sep; (28):4-8. PubMed ID: 11367365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protease inhibitors at Retroviruses Conference: Agouron's results.
    James JS
    AIDS Treat News; 1996 Mar; (no 242):5-6. PubMed ID: 11363194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Raltegravir: new Drug. Alternative to enfuvirtide/darunavir in multidrug-resistant HIV.
    Prescrire Int; 2008 Aug; 17(96):135-7. PubMed ID: 19480091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug resistance genotypes predict response to amprenavir-containing regimens in highly drug-experienced HIV-1-infected patients.
    Sabin CA; Wilkins E; Murphy M; Fisher M; de Ruiter A; Easterbrook PJ; Leen C; Vlahakis E; Cane PA; Li X; Pillay D;
    Antivir Ther; 2003 Aug; 8(4):301-8. PubMed ID: 14518699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. More trouble for adefovir.
    Gilden D
    GMHC Treat Issues; 1999 Apr; 13(4):3. PubMed ID: 11366975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/lamivudine in HIV-infected naive patients (the Combine Study).
    Podzamczer D; Ferrer E; Consiglio E; Gatell JM; Perez P; Perez JL; Luna E; González A; Pedrol E; Lozano L; Ocaña I; Llibre JM; Casiró A; Aranda M; Barrufet P; Martínez-Lacasa J; Miró JM; Badía X; Casado A; Lupo S; Cahn P; Maños M; Estela J
    Antivir Ther; 2002 Jun; 7(2):81-90. PubMed ID: 12212928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental drug available.
    Vazquez E
    Posit Aware; 1998; 9(6):17. PubMed ID: 11366472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of combined zidovudine and lamivudine compared with that of combined zidovudine, lamivudine and nelfinavir in asymptomatic and early symptomatic HIV-infected children.
    Moolasart P; Likanonsakul S
    Southeast Asian J Trop Med Public Health; 2002 Jun; 33(2):280-7. PubMed ID: 12236426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Women's nelfinavir (Viracept) trial.
    Vazquez E
    Posit Aware; 1997; 8(5):15. PubMed ID: 11364633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fifth Conference on Retroviruses & Opportunistic Infections. Interview by Ron Baker.
    Follansbee S; Deeks S; Bartnoff H
    Newsline People AIDS Coalit N Y; 1998 Mar; ():7-14. PubMed ID: 11367453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.